Our Services
Others
- DFPP
- Shockwave
- IV Drip
“Autism healing by stem cell therapy” is a phrase many parents come across online, often next to promises of recovery. So here is the honest answer first. Stem cell therapy cannot cure autism, and no stem cell product is approved to treat it. Autism is a lifelong difference in how the brain develops, shaped mainly by genetics. It is not an injury or an infection that can be “fixed”. Some studies suggest stem cells might ease certain symptoms in some children. The largest, most rigorous trial so far, however, found no overall benefit over placebo.
This article explains what “healing” can realistically mean when it comes to autism and stem cells. It covers the ways stem cells might help, how strong the evidence is for each, how a child’s own cells compare with donor cells, and how to read the cure claims you will find online.
No. There is no medical cure for autism, from stem cells or anything else. Autism is a neurodevelopmental condition. It affects how a person communicates, relates to others and experiences the world, and it begins before birth. Many autistic adults also reject the idea that autism needs curing. What they want is support with the challenges that can come with it, such as communication, sleep, anxiety or self-injury.
Any clinic that promises to cure, reverse or remove autism is making a claim that no published study supports.
No study has shown that stem cells reverse autism. In the best-designed trial to date, 180 autistic children aged 2 to 7 received either cord blood cells or a placebo. Six months later, their autism traits were largely unchanged, and the cells did not improve social skills (Spectrum, 2020). The researchers concluded that the results did not support using cord blood to treat autism outside a formal clinical trial (Dawson et al., 2020).
No. What does exist are well-studied supports that improve daily life and skills. These include early behavioural and developmental therapies, speech and language therapy, occupational therapy, educational support, and medicines for specific problems such as sleep difficulties, anxiety or severe irritability. These are the foundation. Any experimental treatment, including stem cells, should only ever be added on top of them, never used in their place.
No. Autism is not a disease with a cure. The goal of good care is to help each autistic person communicate, learn, stay healthy and live as independently and happily as possible.
When stem cell clinics talk about “autism healing”, parents often hear “my child will no longer be autistic”. That is not a realistic outcome. In research, “improvement” means something much smaller and more specific:
When a study or clinic reports an improvement, ask these three questions.
Why it matters: Autistic children keep developing and learning, especially when they receive speech, occupational and behavioural therapy. If a study only measures children before and after stem cells, part or all of the improvement may come from natural development or ongoing therapy rather than from the cells.
What the evidence shows: Most positive autism stem cell studies had no comparison group. The largest study that did have one, a randomized, placebo-controlled trial of 180 children, found that children who received cord blood did not improve more overall than children who received a placebo (Dawson et al., 2020).
What to look for: A study in which some children received a placebo, and neither families nor assessors knew who got the real treatment. This is called a “double-blind, placebo-controlled” trial.
Why it matters: Parents who have paid for a treatment, often travelled abroad, and hoped hard for change may honestly see more progress than is really there. This is a natural human response called expectation bias, not dishonesty. Clinics that sell the treatment also have a reason to report good results.
What the evidence shows: Many positive reports rely on parent questionnaires. In a four-child case report in Frontiers in Pediatrics, for example, parents reported the improvements using an online checklist (Kobinia et al., 2021). In the Duke trial, trained assessors who did not know which children received cells found no overall difference in social skills (Spectrum, 2020).
What to look for: Results measured by independent, trained clinicians who did not know which treatment each child received.
Why it matters: A result can be “statistically significant” and still be too small to change daily life. A few points on a rating scale may not mean a child can talk more, sleep better or cope better at school. Some effects also fade after a few months.
What the evidence shows: In a 2022 review of controlled studies, children in stem cell groups had somewhat lower autism rating scores. However, clinicians judged overall improvement almost equally in both groups: 62% with stem cells and 60% in the control groups (Qu et al., 2022). Most studies followed children for only 6 to 12 months, so long-term effects are unknown.
What to look for: Changes in everyday skills that matter to your family, measured over at least a year.
At best, researchers are asking whether stem cells might modestly improve certain symptoms in some autistic children, possibly by calming inflammation. That question has not been answered yet. A realistic expectation today is that a child who receives stem cells in a proper trial may see no change, or a small change that may or may not be due to the cells.
| 📌 If you’re interested in how MSCs calm overactive immune cells throughout the body, we have an interesting article that discusses mesenchymal stem cell therapy for immune modulation, which you can read via the internal link. |
“Recovery” in the sense of no longer being autistic has not been shown in any controlled study. Some autistic children make big gains over time through development, therapy and support, with or without stem cells. Be cautious of testimonials that credit stem cells for this progress. The child’s ongoing therapies and natural development are usually also at work.
Researchers have proposed four ways stem cells might help some autistic children. All four are theories still being tested. Most of the supporting evidence comes from animal or laboratory studies, not from children.
An important correction to a common claim: stem cells given through a vein do not travel into the brain and rebuild it. After an intravenous infusion, most cells are caught in the lungs and other organs and survive only a short time. Any effect on the brain is thought to come from the signals they release into the blood, such as anti-inflammatory molecules and tiny vesicles called exosomes, not from the cells themselves settling in the brain.
| 📌 If you’re interested in why the percentage of living cells matters so much at the time of treatment, we have an interesting article that discusses the importance of cell viability in UC-MSC stem cell therapy, which you can read via the internal link. |
| Proposed way stem cells might help | What the idea is | Evidence level |
| Brain repair and neurogenesis | Signals from stem cells support the growth and survival of nerve cells | Very low: laboratory and animal studies only |
| Less inflammation | Stem cells calm overactive immune cells in the brain and body | Low: animal studies and some blood marker changes in small human studies |
| Better nerve connections | Signals support healthier connections (synapses) between nerve cells | Very low: laboratory and animal studies only |
| Immune balance | Stem cells shift the immune system toward a calmer, more regulated state | Low: small human studies with mixed results |
Evidence levels: Moderate means consistent results from randomized controlled trials. Low means small or uncontrolled human studies. Very low means no meaningful human evidence.
There is no evidence that stem cells repair the brain in autistic children. The autistic brain is not “damaged” in the way it might be after a stroke or injury. It developed differently from the start. Claims that stem cells “repair brain cells” or “regenerate the brain” in autism go well beyond what research shows.
Neurogenesis means the creation of new nerve cells. In laboratory studies, signals from mesenchymal stem cells can support nerve cell growth and survival. There is no evidence that stem cell infusions create new nerve cells in autistic children, or that doing so would change autism traits.
Synapses are the junctions where nerve cells pass signals to each other. Research suggests that the way synapses form and are refined may differ in autism. Some scientists have proposed that stem cell signals could influence this. So far, the idea has been explored only in animal and laboratory models.
Synaptic pruning is the brain’s natural process of removing unneeded connections during childhood. Some research suggests pruning may work differently in autism. No human study has shown that stem cells change synaptic pruning in autistic children. Treat any clinic that claims this with caution.
For more on inflammation and brain connectivity in autism, see our dedicated pages: Neuroinflammation and autism and Neural connectivity in autism.
The research is small, mixed and mostly low quality. Here is what the key studies found.
The largest randomized trial (2020). Researchers at Duke University randomly assigned 180 autistic children to a single infusion of cord blood, either the child’s own banked cord blood or a donor’s, or to a placebo. Neither the families nor the assessors knew who received cells. The cord blood was safe and well tolerated, but it did not improve social skills overall (Dawson et al., 2020). The researchers saw hints of benefit in a subgroup of older children without intellectual disability, but an independent expert called these results at best only suggestive.
Meta-analysis (2021). Stem Cell Therapy in the Treatment of Patients With Autism Spectrum Disorder: a Systematic Review and Meta-analysis pooled 11 trials with 461 patients. It reported improvements on some autism rating scales and no serious adverse events (Villarreal-Martínez et al., 2021). However, it included uncontrolled studies, which tend to overstate benefit, and the authors said more studies are needed before we can be confident in the results.
Second meta-analysis (2022). A review of controlled studies in children found lower autism rating scores in stem cell groups. However, on the clinicians’ overall impression of improvement, the two groups were almost identical: 62% with stem cells and 60% in the control groups (Qu et al., 2022).
Case reports (2021). A Frontiers in Pediatrics report described four autistic children treated with their own bone marrow cells, given into the spinal fluid and a vein. Parents reported improvements. With only four children, no control group and parent-reported results, a report like this cannot show that the cells worked. The authors themselves called for larger studies (Kobinia et al., 2021).
Bottom line: Small, uncontrolled studies often look positive. The most rigorous controlled trial did not show an overall benefit. Stem cell therapy for autism remains experimental and belongs in clinical trials.
Two main sources of cells have been tested:
| Own cells (autologous) | Donor cells (allogeneic) | |
| Source | The child’s banked cord blood, or bone marrow | Donated cord blood or cord tissue |
| Procedure for the child | Bone marrow harvest needs anaesthesia; banked cord blood needs none | No harvest needed |
| Immune reaction | None, since they are the child’s own cells | Low with cord tissue MSCs; cord blood may need partial matching |
| Main risk | The harvest procedure (bone marrow) | Depends heavily on donor screening and laboratory quality |
| Evidence in autism | Not better than placebo overall in the largest trial | Not better than placebo overall in the largest trial |
Neither has been proven to work. In the Duke trial, results did not differ meaningfully between the children’s own cord blood and donor cord blood, and neither beat placebo overall (Dawson et al., 2020). If you are considering a clinical trial, the source of the cells matters less than the quality of the trial: proper approval, a control group, independent assessment, and a laboratory that meets recognised standards.
No. The U.S. Food and Drug Administration has not approved any stem cell product to treat autism. The FDA has warned companies marketing unapproved stem cell products for autism, citing risks such as microbial contamination (Spectrum, 2019). The U.S. Federal Trade Commission has also acted against clinics that claimed their treatments could “reverse autism symptoms”.
Outside the United States, most European countries limit stem cell injections to clinical trials. In India, the Supreme Court has ruled that stem cell therapy cannot be offered as a clinical treatment for autism. In Thailand, stem cell treatment for anything other than a short list of blood disorders must take place within research approved by the Medical Council of Thailand.
| 📌 If you’re planning treatment in Thailand and want a practical checklist for choosing a safe clinic, we have an interesting article that discusses whether stem cell therapy is safe in Thailand, which you can read via the internal link. |
Because demand is strong and regulation is weak in some places. An investigation found that parents of autistic children were paying tens of thousands of dollars for unproven stem cell treatments, sometimes using cells of questionable origin, while regulators were slow to act (Spectrum, “False hope for autism in the stem-cell underground”). Parents swap clinic recommendations on social media, and dramatic testimonials spread faster than careful research.
These clinics often use real scientific words, such as neuroinflammation, neurogenesis or immunomodulation, to make an unproven treatment sound established. Science-sounding language does not mean the science supports the treatment.
When you read a clinic’s website or advertisement, ask these six questions. Here is how to answer each one.
Answer: If it does, treat this as a serious warning sign. No published study shows that stem cells cure, reverse or heal autism. The FDA has not approved any stem cell product for autism, and U.S. regulators have taken action against clinics that claimed their treatments could “reverse autism symptoms”. An honest provider uses careful words such as “experimental”, “under research” or “may help some symptoms in some children”, and explains the uncertainty.
Answer: If testimonials and videos are the main evidence, they cannot tell you whether the treatment works. A video of a child who started speaking after stem cells may be genuine, but it does not show that the cells caused the change. Children make progress through development and therapy, with or without stem cells. Testimonials also show only the families who were happy. Families who saw no change rarely appear. Look for published data that includes every child treated, not only the best stories.
Answer: Check what kind of studies it cites, and what they actually found. Many clinics cite reviews or small studies without a comparison group, which tend to overstate benefits. The 2021 meta-analysis, for example, reported improved scores, but it included uncontrolled studies, and its authors said more research is neede. Look for randomized, placebo-controlled trials. Then read their conclusions yourself, not just the clinic’s summary.
Answer: It should. The most important study in this field, the Duke trial of 180 children, did not show an overall benefit of cord blood over placebo (Dawson et al., 2020). A provider that presents only positive findings and leaves this trial out is not giving you the full picture. An honest provider will explain the negative results and why it still thinks further research is worthwhile.
Answer: Ask for the trial registration number and look it up yourself, for example on ClinicalTrials.gov or the Thai Clinical Trials Registry. A legitimate research programme should also have approval from an ethics committee. In Thailand, stem cell use outside a short list of blood disorders must take place within research approved by the Medical Council of Thailand (The Nation, 2024). Be cautious if a clinic calls its service “research” but charges full price, has no registration number, or offers treatment to any child without clear eligibility criteria.
Answer: A trustworthy provider will insist that your child continues speech therapy, occupational therapy, behavioural support, school support and any prescribed medicines. These are the treatments with proven benefits. Be very wary of any provider who suggests stopping or “pausing” these therapies, or who presents stem cells as a replacement for them. Also ask whether your child’s own doctor and therapists will be informed and involved.
A provider who welcomes all six questions and answers them openly, including about uncertainty and negative results, is far more trustworthy than one who promises healing.
Stem cell therapy does not heal or cure autism. The ideas behind it, such as calming inflammation and supporting brain connections, are scientifically interesting, but they have mostly been tested in animals and laboratories. In children, small studies have shown mixed results, and the most rigorous trial did not show an overall benefit. The treatment appears generally safe in well-run studies, but it is not risk-free, and it can be very expensive.
If you are interested in stem cell therapy for your child:
If you would like an honest opinion on whether any research option is appropriate for your child, send us your child’s diagnosis report, current therapies and main challenges via WhatsApp or our consultation form. We will explain what the evidence does and does not show. We will tell you clearly if we do not think stem cell therapy is right for your child.
This article is for general information. It does not replace advice from your child’s doctor or therapists.